496775-61-2,MFCD20926253
Catalog No.:AA00DA3I

496775-61-2 | Eltrombopag

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$46.00   $32.00
- +
5mg
≥98%
in stock  
$123.00   $86.00
- +
10mg
95%
in stock  
$156.00   $109.00
- +
1g
98%
in stock  
$162.00   $114.00
- +
5g
98%
in stock  
$472.00   $330.00
- +
25g
98%
in stock  
$1,543.00 $1,080.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DA3I
Chemical Name:
Eltrombopag
CAS Number:
496775-61-2
Molecular Formula:
C25H22N4O4
Molecular Weight:
442.4666
MDL Number:
MFCD20926253
SMILES:
OC(=O)c1cccc(c1)c1cccc(c1O)N/N=C\1/C(=NN(C1=O)c1ccc(c(c1)C)C)C
Properties
Properties
 
BP:
656.8 °C at 760 mmHg  
Form:
Solid  
MP:
242-244 °C  
Storage:
Light sensitive;Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
812  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5.4  

Synonyms
 
775E612  
Downstream Synthesis Route

[1]CurrentPatentAssignee:CHANGZHOUPHARMACEUTICALFACTORYCO.,LTD.-CN106966984,2017,ALocationinpatent:Paragraph0011;0012;0013;0014;0015;0016;0017;0018

[2]CurrentPatentAssignee:WUHANWUYAOSCIENCETECH-CN111718297,2020,ALocationinpatent:Paragraph0040-0085

[3]CurrentPatentAssignee:EASTPHARMALIMITED-WO2022/71896,2022,A1Locationinpatent:Page/Pagecolumn12-13

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

[6]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN108191763,2018,ALocationinpatent:Paragraph0056;0078;0079;0080

[7]CurrentPatentAssignee:ZHEJIANGA&FUNIVERSITY-CN112979481,2021,ALocationinpatent:Paragraph0054;0059-0060

[8]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/256212,2010,A1Locationinpatent:Page/Pagecolumn14

[9]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2-3

[10]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2015/87845,2015,A1Locationinpatent:Paragraph0226;0227;0228

[11]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2016/35018,2016,A1Locationinpatent:Page/Pagecolumn14-15

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

[1]CurrentPatentAssignee:GALCHIMIASL;CorporacionQuimicoFarmaceuticaEsteveSA-EP2799425,2014,A1

[2]CurrentPatentAssignee:GALCHIMIASL;CorporacionQuimicoFarmaceuticaEsteveSA-WO2014/177517,2014,A1

[1]Srinivasachary,Katuroju;Rajesh,Chennuri;Tiwari,Shashikant;Somannavar;Nadakudity,SailendraKumar;Moturu,KrishnaMurthyV.R.;Bhanuchadar,Samala;Ramadevi,Bhoomireddy[AsianJournalofChemistry,2021,vol.33,#1,p.97-102]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 496775-61-2
Tags:496775-61-2 Molecular Formula|496775-61-2 MDL|496775-61-2 SMILES|496775-61-2 Eltrombopag
Catalog No.: AA00DA3I
496775-61-2,MFCD20926253
496775-61-2 | Eltrombopag
Pack Size: 1mg
Purity: ≥98%
in stock
$46.00 $32.00
Pack Size: 5mg
Purity: ≥98%
in stock
$123.00 $86.00
Pack Size: 10mg
Purity: 95%
in stock
$156.00 $109.00
Pack Size: 1g
Purity: 98%
in stock
$162.00 $114.00
Pack Size: 5g
Purity: 98%
in stock
$472.00 $330.00
Pack Size: 25g
Purity: 98%
in stock
$1,543.00 $1,080.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DA3I
Chemical Name: Eltrombopag
CAS Number: 496775-61-2
Molecular Formula: C25H22N4O4
Molecular Weight: 442.4666
MDL Number: MFCD20926253
SMILES: OC(=O)c1cccc(c1)c1cccc(c1O)N/N=C\1/C(=NN(C1=O)c1ccc(c(c1)C)C)C
Properties
BP: 656.8 °C at 760 mmHg  
Form: Solid  
MP: 242-244 °C  
Storage: Light sensitive;Inert atmosphere;Room Temperature;  
Complexity: 812  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 33  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5.4  
96: 775E612  
Downstream Synthesis Route
496775-61-2    141-43-5    496775-62-3 

[1]CurrentPatentAssignee:CHANGZHOUPHARMACEUTICALFACTORYCO.,LTD.-CN106966984,2017,ALocationinpatent:Paragraph0011;0012;0013;0014;0015;0016;0017;0018

[2]CurrentPatentAssignee:WUHANWUYAOSCIENCETECH-CN111718297,2020,ALocationinpatent:Paragraph0040-0085

[3]CurrentPatentAssignee:EASTPHARMALIMITED-WO2022/71896,2022,A1Locationinpatent:Page/Pagecolumn12-13

[4]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

[6]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-CN108191763,2018,ALocationinpatent:Paragraph0056;0078;0079;0080

[7]CurrentPatentAssignee:ZHEJIANGA&FUNIVERSITY-CN112979481,2021,ALocationinpatent:Paragraph0054;0059-0060

[8]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/256212,2010,A1Locationinpatent:Page/Pagecolumn14

[9]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn2-3

[10]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-US2015/87845,2015,A1Locationinpatent:Paragraph0226;0227;0228

[11]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2016/35018,2016,A1Locationinpatent:Page/Pagecolumn14-15

496775-61-2    496775-62-3 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2006/178518,2006,A1Locationinpatent:Page/Pagecolumn3

1636137-55-7    496775-61-2 

[1]CurrentPatentAssignee:GALCHIMIASL;CorporacionQuimicoFarmaceuticaEsteveSA-EP2799425,2014,A1

[2]CurrentPatentAssignee:GALCHIMIASL;CorporacionQuimicoFarmaceuticaEsteveSA-WO2014/177517,2014,A1

496775-62-3    496775-61-2 

[1]Srinivasachary,Katuroju;Rajesh,Chennuri;Tiwari,Shashikant;Somannavar;Nadakudity,SailendraKumar;Moturu,KrishnaMurthyV.R.;Bhanuchadar,Samala;Ramadevi,Bhoomireddy[AsianJournalofChemistry,2021,vol.33,#1,p.97-102]

Building Blocks More >
4551-72-8
4551-72-8
1H-Pyrrole-2-carboxamide
AA00DA9C | MFCD00273121
4350-54-3
4350-54-3
3-(Pyridin-3-yl)benzonitrile
AA00DABW | MFCD06801828
55063-97-3
55063-97-3
METHYL METHACRYLATE-3,3-D2
AA00DAJI | MFCD01074158
4843-42-9
4843-42-9
3-(Naphthalen-1-yl)propiolic acid
AA00DAOX | MFCD00181398
528531-90-0
528531-90-0
N-(4-Bromo-2-isopropylphenyl)-2-(4-ethylphenoxy)acetamide
AA00DAT8 | MFCD03555609
487021-52-3
487021-52-3
1-[(4-Methoxyphenyl)methyl]-3-(5-nitro-1,3-thiazol-2-yl)urea
AA00DB21 | MFCD08277040
524924-76-3
524924-76-3
3-Methoxy-5-(pyridin-2-ylethynyl)pyridine
AA00DB65 | MFCD28385870
49781-48-8
49781-48-8
2,2-DIFLUOROPROPIONAMIDE
AA00DBAW | MFCD07780126
438030-43-4
438030-43-4
5-(4-Nitrophenyl)-N-(o-tolyl)-4,5-dihydrothiazol-2-amine
AA00DBGP | MFCD03478340
4774-18-9
4774-18-9
2-(Benzyloxy)-6-chloropyrazine
AA00DBN7 | MFCD08691288
Submit
© 2017 AA BLOCKS, INC. All rights reserved.